Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.

Danny Rischin; Kevin J Harrington; Richard Greil; Denis Soulières; Makoto Tahara; Gilberto de Castro; Amanda Psyrri; Irene Braña; Prakash Neupane; Åse Bratland; Thorsten Fuereder; Brett G M Hughes; Ricard Mesía; Nuttapong Ngamphaiboon; Tamara Rordorf; Wan Zamaniah Wan Ishak; Ruey-Long Hong; René Gonzalez Mendoza; Liyi Jia; Diana Chirovsky; Josephine Norquist; Fan Jin; Barbara Burtness

doi:10.1016/j.oraloncology.2022.105815

Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.

Danny Rischin
, Kevin J Harrington
, Richard Greil (Co-author)
, Denis Soulières
, Makoto Tahara
, Gilberto de Castro
, Amanda Psyrri
, Irene Braña
, Prakash Neupane
, Åse Bratland
, Thorsten Fuereder
, Brett G M Hughes
, Ricard Mesía
, Nuttapong Ngamphaiboon
, Tamara Rordorf
, Wan Zamaniah Wan Ishak
, Ruey-Long Hong
, René Gonzalez Mendoza
, Liyi Jia
, Diana Chirovsky

Josephine Norquist, Fan Jin, Barbara Burtness

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

30 Citations (Web of Science)

Original language	English
Pages (from-to)	105815
Journal	ORAL ONCOLOGY
Volume	128
DOIs	https://doi.org/10.1016/j.oraloncology.2022.105815
Publication status	Published - 2022

Keywords

EUROPEAN-ORGANIZATION
CANCER
NIVOLUMAB
CETUXIMAB
PEMBROLIZUMAB

Access to Document

10.1016/j.oraloncology.2022.105815

Cite this

Rischin, D., Harrington, K. J., Greil, R., Soulières, D., Tahara, M., de Castro, G., Psyrri, A., Braña, I., Neupane, P., Bratland, Å., Fuereder, T., Hughes, B. G. M., Mesía, R., Ngamphaiboon, N., Rordorf, T., Ishak, W. Z. W., Hong, R.-L., Mendoza, R. G., Jia, L., ... Burtness, B. (2022). Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048. ORAL ONCOLOGY, 128, 105815. https://doi.org/10.1016/j.oraloncology.2022.105815

@article{c550e2fcaf614bd38e51ea93acacd63a,

title = "Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.",

keywords = "EUROPEAN-ORGANIZATION, CANCER, NIVOLUMAB, CETUXIMAB, PEMBROLIZUMAB",

author = "Danny Rischin and Harrington, \{Kevin J\} and Richard Greil and Denis Souli{\`e}res and Makoto Tahara and \{de Castro\}, Gilberto and Amanda Psyrri and Irene Bra{\~n}a and Prakash Neupane and {\AA}se Bratland and Thorsten Fuereder and Hughes, \{Brett G M\} and Ricard Mes{\'i}a and Nuttapong Ngamphaiboon and Tamara Rordorf and Ishak, \{Wan Zamaniah Wan\} and Ruey-Long Hong and Mendoza, \{Ren{\'e} Gonzalez\} and Liyi Jia and Diana Chirovsky and Josephine Norquist and Fan Jin and Barbara Burtness",

note = "Greil: Hematology and Medical Oncology, Paracelsus Medical University, Salzburg Cancer Research Institute, and Cancer Cluster Salzburg, Hellbrunner Strasse 34, Salzburg 5020, Austria",

year = "2022",

doi = "10.1016/j.oraloncology.2022.105815",

language = "English",

volume = "128",

pages = "105815",

journal = "ORAL ONCOLOGY",

issn = "1368-8375",

}

Rischin, D, Harrington, KJ, Greil, R, Soulières, D, Tahara, M, de Castro, G, Psyrri, A, Braña, I, Neupane, P, Bratland, Å, Fuereder, T, Hughes, BGM, Mesía, R, Ngamphaiboon, N, Rordorf, T, Ishak, WZW, Hong, R-L, Mendoza, RG, Jia, L, Chirovsky, D, Norquist, J, Jin, F & Burtness, B 2022, 'Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.', ORAL ONCOLOGY, vol. 128, pp. 105815. https://doi.org/10.1016/j.oraloncology.2022.105815

TY - JOUR

T1 - Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.

AU - Rischin, Danny

AU - Harrington, Kevin J

AU - Greil, Richard

AU - Soulières, Denis

AU - Tahara, Makoto

AU - de Castro, Gilberto

AU - Psyrri, Amanda

AU - Braña, Irene

AU - Neupane, Prakash

AU - Bratland, Åse

AU - Fuereder, Thorsten

AU - Hughes, Brett G M

AU - Mesía, Ricard

AU - Ngamphaiboon, Nuttapong

AU - Rordorf, Tamara

AU - Ishak, Wan Zamaniah Wan

AU - Hong, Ruey-Long

AU - Mendoza, René Gonzalez

AU - Jia, Liyi

AU - Chirovsky, Diana

AU - Norquist, Josephine

AU - Jin, Fan

AU - Burtness, Barbara

N1 - Greil: Hematology and Medical Oncology, Paracelsus Medical University, Salzburg Cancer Research Institute, and Cancer Cluster Salzburg, Hellbrunner Strasse 34, Salzburg 5020, Austria

PY - 2022

Y1 - 2022

KW - EUROPEAN-ORGANIZATION

KW - CANCER

KW - NIVOLUMAB

KW - CETUXIMAB

KW - PEMBROLIZUMAB

U2 - 10.1016/j.oraloncology.2022.105815

DO - 10.1016/j.oraloncology.2022.105815

M3 - Original Article

C2 - 35381576

SN - 1368-8375

VL - 128

SP - 105815

JO - ORAL ONCOLOGY

JF - ORAL ONCOLOGY

ER -